Clinical Trial Update: Post-Market Clinical Follow-Up of the CT3 Series Continuous Glucose Monitoring System: A 14-Day Observational Study Assessing Accuracy, Safety, and Glucose Control in Patients With Type 1 and Type 2 Diabetes Mellitus

View source ↗

Summary

A post-market clinical follow-up study evaluating the accuracy, safety, and glucose control of the CT3 Series continuous glucose monitoring system in adults wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Snippet

Sponsor: MDCECRO LLC | Conditions: Diabetes Mellitus | Status: ENROLLING_BY_INVITATION